COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 1707: Articles 17061-17070  | Next

COVID-19 with early neurological and cardiac thromboembolic phenomena--timeline of incidence and clinical features
Sundar, U., Merchant, S., Shah, M., Mukhopadhyay, A., Kolte, S., Darole, P., Mahajan, S., Bansal, A., Gosavi, S., Asole, D., Karnik, N., Mahajan, A., Joshi, A.
10.1101/2021.03.15.21253619 — Posted: 2021-03-17
PD-1highCXCR5-CD4+ Peripheral Helper T (Tph) cells Promote Tissue-Homing Plasmablasts in COVID-19
Asashima, H., Mohanty, S., Comi, M., Ruff, W. E., Hoehn, K. B., Wong, P., Cohen, I., Coffey, S., Raddassi, K., Chaudhary, O., Unterman, A., Emu, B., Kleinstein, S. H., Montgomery, R. R., Iwasaki, A., Dela Cruz, C. S., Kaminski, N., Shaw, A. C., Hafler, D. A., Sumida, T. S.
10.1101/2021.03.13.21253527 — Posted: 2021-03-17
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values
Alizon, S., Selinger, C., Sofonea, M. T., Haim-Boukobza, S., Giannoli, J.-M., Ninove, L., Pillet, S., Vincent, T., de Rougemont, A., Tumiotto, C., Solis, M., Stephan, R., Bressollette-Bodin, C., Salmona, M., L'Honneur, A.-S., Behillil, S., Lefeuvre, C., Dina, J., Hantz, S., Hartard, C., Veyer, D., Delagreverie, H. M., Fourati, S., Visseaux, B., Henquell, C., Lina, B., Foulougne, V., Burrel, S.
10.1101/2021.03.15.21253653 — Posted: 2021-03-17
A bibliometric analysis of COVID-19 research in Africa
Guleid, F. H., Oyando, R., Kabia, E., Mumbi, A., Akech, S., Barasa, E.
10.1101/2021.03.15.21253589 — Posted: 2021-03-17
Faecal shedding models for SARS-CoV-2 RNA amongst hospitalised patients and implications for wastewater-based epidemiology
Hoffmann, T., Alsing, J.
10.1101/2021.03.16.21253603 — Posted: 2021-03-17
Hospitalisation rates differed by city district and ethnicity during the first wave of COVID-19 in Amsterdam, the Netherlands
Coyer, L., Wynberg, E., Buster, M., Wijffels, C., Prins, M., Schreijer, A., van Duijnhoven, Y. T. H. P., van Dam, A., van der Lubben, M., Leenstra, T.
10.1101/2021.03.15.21253597 — Posted: 2021-03-17
Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19
Webb, B. J., Buckel, W., Vento, T., Butler, A. M., Grisel, N., Brown, S. M., Peltan, I. D., Spivak, E. S., Shah, M., Sakata, T., Wallin, A., Stenehjem, E., Poulsen, G., Bledsoe, J.
10.1101/2021.03.15.21253646 — Posted: 2021-03-17
Lessons learned from the resilience of Chinese hospitals to the COVID-19 pandemic: a scoping review.
Stennett, J., Hou, R., Traverson, L., Ridde, V., Zinszer, K., Chabrol, F.
10.1101/2021.03.15.21253509 — Posted: 2021-03-17
A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance
Karim, M. A., Shilts, J., Schwartzentruber, J., Hayhurst, J., Buniello, A., Mohammed, E. S. E., Zheng, J., Holmes, M. V., Ochoa, D., Carmona, M., Maranville, J., Gaunt, T. R., Emilsson, V., Gudnason, V., McDonagh, E. M., Wright, G. J., Ghoussaini, M., Dunham, I.
10.1101/2021.03.15.21253625 — Posted: 2021-03-17
Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics
Wong, S.-Y., Gold, S., Accorsi, E. K., Cowger, T. L., Wiseman, D., Navalurkar, R., Dixon, R., Helmus, D. S., CiTI Study Group, , Firpo-Betancourt, A., Mendu, D. R., Zolla-Pazner, S., Cadwell, K., Colombel, J.-F.
10.1101/2021.03.15.21253615 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).